Bristol-Myers Squibb (United States)

Unspecified (Unknown)

Start Date End Date Funded Value Relevance

CSV

25 50 100

Oct 16 - Dec 20

Understanding how immunomodulatory drugs affect tumour microenvironment (TME)-driven immune suppression.

MRC award to King's College London

Oct 21 - Sep 26

Activity-based probes as chemical tool to identify protease involved in mRNA splicing

EPSRC award to Newcastle University

£583,941

Mar 15 - Mar 20

MICA: Early phase clinical trial repurposing ATRA as stromal targeting agent in a novel drug combination for pancreatic cancer (STAR-PAC)

MRC award to Queen Mary University of London and Hemant Kocher

{{facetGroup.name}}

{{getFilterText(facet,showCount)}}